RecruitingNCT03178149
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
PHASE1 · 42 planned enrolment
- Countries listed
- 1
- Registry update
- September 3, 2026
